Goncharova I A, Rachkovskiĭ M I, Beloborodova E V, Gamal' Abd El'-Aziz Nasar Kh, Puzyrev V P
Mol Biol (Mosk). 2010 May-Jun;44(3):431-8. doi: 10.1134/s0026893310030118.
Association of deletion polymorphism in GSTT1 and GSTM1 genes and polymorphic variant A313G of GSTP1 gene with cirrhosis diseases and 4-year survival rate for the Tomsk region (West Siberia) patients were tested. Homozygous deletion of GSTM1 gene (null genotype) was a protective factor for alcoholic and mixed (HCV, HBV and alcohol) liver cirrhosis development. The patients from the joint group (all etiology forms) as well as having alcoholic and mixed cirrhosis had lower frequency of GSTM1 null genotype (39.2, 39.0, and 34.2%, respectively) in comparison with the control group (64.6%). The GSTM1 null genotype and GSTP1 gene A313G polymorphic variant correlated with the patients' survival rate. The patients survived in comparison with the dead had higher frequency of a GSTM1 null genotype (46.6 vs. 30.2%) and GSTP1 AA genotype (63.1 vs. 40.5%), and lower frequency of GSTP1 AG (A313G) genotype (31.1 vs. 51.2%). A survival rate was 2.5 times higher for patients having GSTP1 AA genotype in comparison with the GG and AG genotype carriers and 2 times higher for patients having GSTM1 null genotype than the gene carriers. A 4-year fatal case probability was 2.3 times higher among the patients having heterozygous AG GSTP1 genotype in comparison with homozygous AA and GG genotype carriers.
对托木斯克地区(西西伯利亚)患者的谷胱甘肽 S - 转移酶 T1(GSTT1)基因缺失多态性、谷胱甘肽 S - 转移酶 M1(GSTM1)基因与谷胱甘肽 S - 转移酶 P1(GSTP1)基因多态性变体 A313G 与肝硬化疾病及 4 年生存率之间的关联进行了检测。GSTM1 基因的纯合缺失(无效基因型)是酒精性和混合性(丙型肝炎病毒、乙型肝炎病毒和酒精)肝硬化发展的保护因素。联合组(所有病因形式)以及患有酒精性和混合性肝硬化的患者中,GSTM1 无效基因型的频率(分别为 39.2%、39.0%和 34.2%)低于对照组(64.6%)。GSTM1 无效基因型和 GSTP1 基因 A313G 多态性变体与患者生存率相关。存活患者与死亡患者相比,GSTM1 无效基因型(46.6%对 30.2%)和 GSTP1 AA 基因型(63.1%对 40.5%)的频率更高,而 GSTP1 AG(A313G)基因型(31.1%对 51.2%)的频率更低。与携带 GG 和 AG 基因型的患者相比,携带 GSTP1 AA 基因型的患者生存率高 2.5 倍;与基因携带者相比,具有 GSTM1 无效基因型的患者生存率高 2 倍。与纯合 AA 和 GG 基因型携带者相比,携带杂合 AG GSTP1 基因型的患者 4 年致死概率高 2.3 倍。